| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.28 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |